Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Divine Skin Inc. Stories

2012-06-25 06:32:10

MIAMI BEACH, Fla., June 25, 2012 /PRNewswire/ -- Divine Skin today announced that it was granted a Drug Enforcement Agency license in partnership with its manufacturing partner to produce and distribute Ephedrine containing drugs and other controlled substances. The Company has started working on a new OTC analgesic, which it believes could provide an alternative to current OTC pain relievers. Receiving this mandatory license is the final step in commencing manufacturing of its OTC pain...

2012-05-16 06:26:57

MIAMI BEACH, Fla., May 16, 2012 /PRNewswire/ -- Divine Skin Inc. (OTCBB: DSKX), a leading developer of personal-care products, announced results for its quarter ending March 31, 2012. Net revenue was $1.98 million, compared to $2.25 million in the same quarter of 2011. Gross margin improved significantly, to more than 50 percent or $1.05 million, comparable to last year's quarterly result of $1.10 million. Net loss for the quarter was $428,000, compared to $192,000 for the first quarter of...

2012-04-11 02:24:42

MIAMI BEACH, Fla., April 11, 2012 /PRNewswire/ -- Divine Skin Inc. (DSKX) (OTC Bulletin Board: DSKX), a leading developer of personal-care products, announced that it closed a $1.5 million line of credit with MidCap Business Credit LLC in a move that will continue to fuel the explosive growth the company is experiencing. Divine Skin CEO Daniel Khesin stated, "Securing the right funding to finance our growth is just one more step in the right direction as we continue to see stellar...

2012-03-22 02:25:11

MIAMI BEACH, Fla., March 22, 2012 /PRNewswire/ -- Today Divine Skin Inc., (OTC Bulletin Board: DSKX), a leading developer of cutting-edge biotechnology for hair and skin, announced that it had signed a letter of intent to acquire 100 percent of Divine Skin Laboratories SA de CV in stock. In 2011, the Mexican company represented nearly 10 percent of Divine Skin's revenue. It has been a distributor of Divine Skin product for more than three years, with sales growing quickly year over year....

2012-02-28 07:00:00

MIAMI BEACH, Fla., Feb. 28, 2012 /PRNewswire/ --Today Divine Skin Inc. (OTC Bulletin Board: DSKX) announced that it has taken its first NutraOrigin supplement order from United Natural Foods, Inc. (NWFI). "We are thrilled to be working with United Natural Foods," said Daniel Khesin, Divine Skin's CEO. "We believe this relationship will take the NutraOrigin brand to a new level of distribution, and we are looking forward to a very rewarding relationship together." About United Natural...

2012-02-09 07:00:00

MIAMI BEACH, Fla., Feb. 9, 2012 /PRNewswire/ -- Today Divine Skin (OTC Bulletin Board: DSKX) released preliminary revenue figures for the fourth quarter, $3.1 million, up 63 percent over the same quarter of 2010 and up 48 percent over the third quarter of 2011. For the year 2011, revenue totaled $9.6 million, up 78 percent over 2010. Divine Skin CEO Daniel Khesin said, "While we experienced nearly triple-digit growth in 2011, we are far from satisfied with this result. We believe...

2011-12-21 10:09:00

MIAMI BEACH, Fla., Dec. 21, 2011 /PRNewswire/ -- The team at Divine Skin (OTC Bulletin Board: DSKX) has been working to maintain strong growth and exceed expectations across its diverse consumer goods business and accelerate development through its strong biotechnology program. Some highlights for the year include: RECORD 2010 REVENUE. Divine Skin started the year by announcing record sales for 2010 ($5.4 million), up $1.9 million or 55 percent over 2009. RECORD 2011 QUARTERS....

2011-11-30 07:00:00

MIAMI BEACH, Fla., Nov. 30, 2011 /PRNewswire/ -- Divine Skin Inc. (DSKX.ob) confirmed that NutraOrigin, its brand of 63 premium nutritional supplements, had been tested successfully in four of the roughly 300 US locations of Whole Foods Market Inc., and that NutraOrigin would propagate throughout the upscale chain in 2012. Distribution began with NutraOrigin's Omega line, the first brand of high-potency omega-3 fatty acids proven effective in large-scale clinical trials. During a recent...

2011-11-15 07:00:00

MIAMI BEACH, Fla., Nov. 15, 2011 /PRNewswire/ -- Biotechnology leader Divine Skin Inc., (OTC Bulletin Board: DSKX) which develops personal care products, posted revenue of $2.1 million for the third quarter, up 35 percent from 2010. The rapidly expanding company reported nine-month revenue of $6.6 million, up 74 percent from last year. "We are on track for another record-breaking year," said Divine Skin CEO Daniel Khesin. "These days, there are so many opportunities to commercialize new...

2011-11-09 07:00:00

MIAMI BEACH, Fla., Nov. 9, 2011 /PRNewswire/ -- Biotech developer Divine Skin Inc. (OTC Bulletin Board: DSKX) which has been expanding the topical hair-growth segment, is rolling out that market's newest, most potent, only customizable system, Polaris API Solution 9, to be supplied by physicians for treatment through multiple methods of action. With well-established materials like minoxidil sulfate, finasteride, alfatradiol, and other active ingredients, Polaris API Solution 9 is the most...